Financial Year |
March 31 2023 |
Monetary Funds |
1,647,397,564.55 |
Held-for-trading Financial Assets |
195,223,611.63 |
Notes Receivable |
-- |
Accounts Receivable |
218,832.94 |
Advances to Suppliers |
-- |
Other Receivables |
10,563,621.77 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
355,312,182.80 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
-- |
Total Current Assets |
2,208,715,813.69 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
1,274,516,783.22 |
Long-term Equity Investment |
1,846,542,979.16 |
Investment Properties |
532,529.46 |
Fixed Assetes |
108,220,916.00 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
-- |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
-- |
Other Non-Current Assets |
137,203,803.45 |
Sub-Total of Non-Current Assets |
4,718,820,406.64 |
Total Assets |
6,927,536,220.33 |
Short-Term Loans |
707,392,500.00 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
1,653,822.38 |
Accounts Received In Advance |
831,895.22 |
Employee Compensation Payable |
4,021,812.40 |
Taxes Payable |
24,731,942.01 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
3,263,479.92 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
109,540,211.75 |
Other Current Liabilities |
-- |
Sub-Total of Current Liabilities |
851,435,663.68 |
Long-term Loans |
1,133,550,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
366,556,546.92 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
1,506,317,292.78 |
Total Liabilities |
2,357,752,956.46 |
Paid-In Capital(Or Share Stock) |
1,329,025,062.00 |
Capital Surplus |
54,290,513.40 |
Surplus Reserve |
488,488,826.35 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
1,949,005,149.46 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,569,783,263.87 |
Owner's Equity(Stockholder's Equity) |
4,569,783,263.87 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
6,927,536,220.33 |